106 related articles for article (PubMed ID: 38819371)
1. Dual-targeting of tumor cells and subcellular endoplasmic reticulum
Ma K; Diao H; Xu X; Jin Y; Qiu M; Liu Z; Yang C; Zhao J; Chai S; Fang Q; Guo Z; Cui C; Xu J; Yin L; Ma HY
Nanoscale; 2024 May; ():. PubMed ID: 38819371
[TBL] [Abstract][Full Text] [Related]
2. Endoplasmic reticulum-targeted NIR-II phototherapy combined with inflammatory vascular suppression elicits a synergistic effect against TNBC.
Wan G; Chen X; Chen J; Gou R; Wang H; Liu S; Zhang M; Chen H; Wang D; Zhang Q
Biomater Sci; 2023 Feb; 11(5):1876-1894. PubMed ID: 36692120
[TBL] [Abstract][Full Text] [Related]
3. Tumor Cell Targeting and Responsive Nanoplatform for Multimodal-Imaging Guided Chemodynamic/Photodynamic/Photothermal Therapy toward Triple Negative Breast Cancer.
Li L; Li J; Hu R; Zhang X; Ding L; Ren G; Liu W; Wang H; Wang B; Zhang C; Diao H
ACS Appl Mater Interfaces; 2023 Jun; 15(23):27706-27718. PubMed ID: 37261936
[TBL] [Abstract][Full Text] [Related]
4. Engineering nanoparticles boost TNBC therapy by CD24 blockade and mitochondrial dynamics regulation.
Zhao M; Li J; Chen F; Han Y; Chen D; Hu H
J Control Release; 2023 Mar; 355():211-227. PubMed ID: 36736908
[TBL] [Abstract][Full Text] [Related]
5. Nanodrugs mediate TAMs-related arginine metabolism interference to boost photodynamic immunotherapy.
Chen Y; Shu X; Guo JY; Xiang Y; Liang SY; Lai JM; Zhou JY; Liu LH; Wang P
J Control Release; 2024 Mar; 367():248-264. PubMed ID: 38272398
[TBL] [Abstract][Full Text] [Related]
6. A MCL-1-targeted photosensitizer to combat triple-negative breast cancer with enhanced photodynamic efficacy, sensitization to ROS-induced damage, and immune response.
Huang K; Yao H; Yan M; Zhang H; Yuan G; Wang Q; Xue J; Li J; Chen J
J Inorg Biochem; 2022 Dec; 237():111997. PubMed ID: 36137402
[TBL] [Abstract][Full Text] [Related]
7. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
[TBL] [Abstract][Full Text] [Related]
8. Theranostic nanoparticles for enzyme-activatable fluorescence imaging and photodynamic/chemo dual therapy of triple-negative breast cancer.
Choi J; Kim H; Choi Y
Quant Imaging Med Surg; 2015 Oct; 5(5):656-64. PubMed ID: 26682135
[TBL] [Abstract][Full Text] [Related]
9. Oligo-Fucoidan supplementation enhances the effect of Olaparib on preventing metastasis and recurrence of triple-negative breast cancer in mice.
Chen LM; Yang PP; Al Haq AT; Hwang PA; Lai YC; Weng YS; Chen MA; Hsu HL
J Biomed Sci; 2022 Sep; 29(1):70. PubMed ID: 36109724
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional Novel Nanoplatform for Effective Synergistic Chemo-Photodynamic Therapy of Breast Cancer by Enhancing DNA Damage and Disruptions of Its Reparation.
Huang Z; Xian T; Meng X; Hu H; Gao L; Huang J; Yang D; Ou K; Wang B; Zhang Y
Molecules; 2023 Oct; 28(19):. PubMed ID: 37836815
[TBL] [Abstract][Full Text] [Related]
11. The Streptococcus virulence protein PepO triggers anti-tumor immune responses by reprograming tumor-associated macrophages in a mouse triple negative breast cancer model.
Liu B; Huang J; Xiao J; Xu W; Zhang H; Yuan Y; Yin Y; Zhang X
Cell Biosci; 2023 Nov; 13(1):198. PubMed ID: 37925462
[TBL] [Abstract][Full Text] [Related]
12. Enhanced anti-tumor efficacy by inhibiting HIF-1α to reprogram TAMs
Zhang LJ; Huang R; Shen YW; Liu J; Wu Y; Jin JM; Zhang H; Sun Y; Chen HZ; Luan X
Biomater Sci; 2021 Sep; 9(19):6403-6415. PubMed ID: 34259235
[TBL] [Abstract][Full Text] [Related]
13. Combination of verteporfin-photodynamic therapy with 5-aza-2'-deoxycytidine enhances the anti-tumour immune response in triple negative breast cancer.
Banerjee SM; Acedo P; El Sheikh S; Harati R; Meecham A; Williams NR; Gerard G; Keshtgar MRS; MacRobert AJ; Hamoudi R
Front Immunol; 2023; 14():1188087. PubMed ID: 38022682
[TBL] [Abstract][Full Text] [Related]
14. Photosensitive small extracellular vesicles regulate the immune microenvironment of triple negative breast cancer.
Ding YN; Ding HY; Li H; Yang R; Huang JY; Chen H; Wang LH; Wang YJ; Hu CM; An YL; Zhang ZY; Yu WP; Tang QS; Shao GL
Acta Biomater; 2023 Sep; 167():534-550. PubMed ID: 37302734
[TBL] [Abstract][Full Text] [Related]
15. An Intelligent Biomimetic Nanoplatform for Holistic Treatment of Metastatic Triple-Negative Breast Cancer
Cheng Y; Chen Q; Guo Z; Li M; Yang X; Wan G; Chen H; Zhang Q; Wang Y
ACS Nano; 2020 Nov; 14(11):15161-15181. PubMed ID: 33143424
[TBL] [Abstract][Full Text] [Related]
16. Remotely Phototriggered, Transferrin-Targeted Polymeric Nanoparticles for the Treatment of Breast Cancer.
Jadia R; Kydd J; Rai P
Photochem Photobiol; 2018 Jul; 94(4):765-774. PubMed ID: 29427385
[TBL] [Abstract][Full Text] [Related]
17. Targeting Bone Tumor and Subcellular Endoplasmic Reticulum via Near Infrared II Fluorescent Polymer for Photodynamic-Immunotherapy to Break the Step-Reduction Delivery Dilemma.
Zhang X; Wan J; Mo F; Tang D; Xiao H; Li Z; Jia J; Liu T
Adv Sci (Weinh); 2022 Aug; 9(24):e2201819. PubMed ID: 35754296
[TBL] [Abstract][Full Text] [Related]
18. Dual tumor- and subcellular-targeted photodynamic therapy using glucose-functionalized MoS
Xu S; Zhang P; Heing-Becker I; Zhang J; Tang P; Bej R; Bhatia S; Zhong Y; Haag R
Biomaterials; 2022 Nov; 290():121844. PubMed ID: 36302305
[TBL] [Abstract][Full Text] [Related]
19. Tumor microcalcification-mediated relay drug delivery for photodynamic immunotherapy of breast cancer.
Jian H; Wang X; Song P; Wu X; Zheng R; Wang Y; Zhang H
Acta Biomater; 2022 Mar; 140():518-529. PubMed ID: 34923096
[TBL] [Abstract][Full Text] [Related]
20. A prodrug hydrogel with tumor microenvironment and near-infrared light dual-responsive action for synergistic cancer immunotherapy.
Ding M; Fan Y; Lv Y; Liu J; Yu N; Kong D; Sun H; Li J
Acta Biomater; 2022 Sep; 149():334-346. PubMed ID: 35779775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
